ABBOTT OMNIFLOX HEMOLYTIC ANEMIA REPORTS FIRST REACHED FDA IN EARLY MAY; ABBOTT HAS NO PLANS TO RESURRECT PRODUCT FOLLOWING JUNE 5 WITHDRAWAL